Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer

Abstract Polymorphic variants in the PTEN (rs2735343), PI3K (rs2699887), AKT1 (rs2494750), AR (rs17302090), and AMACR (rs3195676) genes were evaluated as possible molecular markers of susceptibility, prognosis, and progression of prostate cancer (PCa), in a case-control study. Samples consisted of 2...

Full description

Bibliographic Details
Main Authors: Monyse de Nóbrega, Heloisa Lizotti Cilião, Marilesia Ferreira de Souza, Milene Roldão de Souza, Juliana Mara Serpeloni, Paulo Emilio Fuganti, Ilce Mara de Syllos Cólus
Format: Article
Language:English
Published: Sociedade Brasileira de Genética
Series:Genetics and Molecular Biology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572020000500101&lng=en&tlng=en
_version_ 1818258038506651648
author Monyse de Nóbrega
Heloisa Lizotti Cilião
Marilesia Ferreira de Souza
Milene Roldão de Souza
Juliana Mara Serpeloni
Paulo Emilio Fuganti
Ilce Mara de Syllos Cólus
author_facet Monyse de Nóbrega
Heloisa Lizotti Cilião
Marilesia Ferreira de Souza
Milene Roldão de Souza
Juliana Mara Serpeloni
Paulo Emilio Fuganti
Ilce Mara de Syllos Cólus
author_sort Monyse de Nóbrega
collection DOAJ
description Abstract Polymorphic variants in the PTEN (rs2735343), PI3K (rs2699887), AKT1 (rs2494750), AR (rs17302090), and AMACR (rs3195676) genes were evaluated as possible molecular markers of susceptibility, prognosis, and progression of prostate cancer (PCa), in a case-control study. Samples consisted of 277 patients with PCa and 277 controls from Londrina, PR, Brazil. SNPs were analyzed by real-time PCR. A family history of cancer, including PCa, as well as level of schooling were risk factors for PCa. The data were obtained via logistic regression, using odds ratios with a CI 95%. The genotypes of AKT1 and AKT1+AR demonstrated an association with protection for the disease. The combination of SNPs with the histopathological tumor data between allele variants of AMACR, AKT1+AR, and AKT1+AMACR indicated an association with protection against seminal vesicle invasion. The polymorphisms AKT1+AR and PI3K+AR were associated with protection against tumor bilaterality. The genotype combinations PTEN+AMACR and PTEN+AR were associated with the risk of extracapsular extension. Of the five genes studied, two were associated with protection for PCa, four were associated with protection for some prognostic variables, and only one was associated with risk. Thus, these SNPs are candidates for markers to discriminate men with better or worse prognosis for PCa.
first_indexed 2024-12-12T17:53:11Z
format Article
id doaj.art-836408e6bb1141c8b8bf51fea10b3350
institution Directory Open Access Journal
issn 1415-4757
1678-4685
language English
last_indexed 2024-12-12T17:53:11Z
publisher Sociedade Brasileira de Genética
record_format Article
series Genetics and Molecular Biology
spelling doaj.art-836408e6bb1141c8b8bf51fea10b33502022-12-22T00:16:47ZengSociedade Brasileira de GenéticaGenetics and Molecular Biology1415-47571678-468543310.1590/1678-4685-gmb-2018-0329S1415-47572020000500101Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancerMonyse de NóbregaHeloisa Lizotti CiliãoMarilesia Ferreira de SouzaMilene Roldão de SouzaJuliana Mara SerpeloniPaulo Emilio FugantiIlce Mara de Syllos CólusAbstract Polymorphic variants in the PTEN (rs2735343), PI3K (rs2699887), AKT1 (rs2494750), AR (rs17302090), and AMACR (rs3195676) genes were evaluated as possible molecular markers of susceptibility, prognosis, and progression of prostate cancer (PCa), in a case-control study. Samples consisted of 277 patients with PCa and 277 controls from Londrina, PR, Brazil. SNPs were analyzed by real-time PCR. A family history of cancer, including PCa, as well as level of schooling were risk factors for PCa. The data were obtained via logistic regression, using odds ratios with a CI 95%. The genotypes of AKT1 and AKT1+AR demonstrated an association with protection for the disease. The combination of SNPs with the histopathological tumor data between allele variants of AMACR, AKT1+AR, and AKT1+AMACR indicated an association with protection against seminal vesicle invasion. The polymorphisms AKT1+AR and PI3K+AR were associated with protection against tumor bilaterality. The genotype combinations PTEN+AMACR and PTEN+AR were associated with the risk of extracapsular extension. Of the five genes studied, two were associated with protection for PCa, four were associated with protection for some prognostic variables, and only one was associated with risk. Thus, these SNPs are candidates for markers to discriminate men with better or worse prognosis for PCa.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572020000500101&lng=en&tlng=ensnpprognosisrs2494750rs2735343rs3195676
spellingShingle Monyse de Nóbrega
Heloisa Lizotti Cilião
Marilesia Ferreira de Souza
Milene Roldão de Souza
Juliana Mara Serpeloni
Paulo Emilio Fuganti
Ilce Mara de Syllos Cólus
Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer
Genetics and Molecular Biology
snp
prognosis
rs2494750
rs2735343
rs3195676
title Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer
title_full Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer
title_fullStr Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer
title_full_unstemmed Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer
title_short Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer
title_sort association of polymorphisms of pten akt1 pi3k ar and amacr genes in patients with prostate cancer
topic snp
prognosis
rs2494750
rs2735343
rs3195676
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572020000500101&lng=en&tlng=en
work_keys_str_mv AT monysedenobrega associationofpolymorphismsofptenakt1pi3karandamacrgenesinpatientswithprostatecancer
AT heloisalizotticiliao associationofpolymorphismsofptenakt1pi3karandamacrgenesinpatientswithprostatecancer
AT marilesiaferreiradesouza associationofpolymorphismsofptenakt1pi3karandamacrgenesinpatientswithprostatecancer
AT mileneroldaodesouza associationofpolymorphismsofptenakt1pi3karandamacrgenesinpatientswithprostatecancer
AT julianamaraserpeloni associationofpolymorphismsofptenakt1pi3karandamacrgenesinpatientswithprostatecancer
AT pauloemiliofuganti associationofpolymorphismsofptenakt1pi3karandamacrgenesinpatientswithprostatecancer
AT ilcemaradesylloscolus associationofpolymorphismsofptenakt1pi3karandamacrgenesinpatientswithprostatecancer